Skip to main content
SpringerLink
Log in

Urinary Tract Infections of the Neurogenic Bladder

  • Chapter
  • First Online:
Female Urinary Tract Infections in Clinical Practice

Part of the book series: In Clinical Practice ((ICP))

Abstract

Patients with neurogenic lower urinary tract dysfunction (NLUTD) are at increased risk of recurrent urinary tract infection (UTI), with much higher incidence reported compared with a “normal” population. As a result, this leads to increased utilisation of healthcare resources as well as morbidity and even mortality in some cases. As expected, the underlying cause, as well as the investigation and management of UTIs in this unique population is different to patients with a “normal” bladder and will be explored further by this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dorsher PT, McIntosh PM. Neurogenic bladder. Adv Urol. 2012;2012:816274. https://doi.org/10.1155/2012/816274. [published online February 8, 2012]

    Article  PubMed  PubMed Central  Google Scholar 

  2. Verhoef M, Lurvink M, Barf HA, et al. High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord. 2005;43:331–40.

    Article  CAS  Google Scholar 

  3. McNeal, D. M., Hawtrey, C. E., Wolraich, M. L. and Mapel, J. R. Symptomatic neurogenic bladder in a cerebral-palsied population. Dev Med Child Neurol. 1983;25(612).

    Article  Google Scholar 

  4. Lansang RS, Krouskop AC. Bladder management. In: Massagli TL, et al., editors. eMedicine. 2004.

    Google Scholar 

  5. Goetz LL, Klausner AP. Strategies for prevention of urinary tract infections in neurogenic bladder dysfunction. Phys Med Rehabil Clin N Am. 2014;25(3):605–18.

    Article  Google Scholar 

  6. McKibben MJ, Seed P, Ross SS, Borawski KM. Urinary tract infection and neurogenic bladder. Urol Clin North Am. 2015;42(4):527–36. 6.

    Article  Google Scholar 

  7. Bergamin PA, Kiosoglous AJ. Surgical management of recurrent urinary tract infections: a review. Transl Androl Urol. 2017;6(Suppl 2):S153–62.

    Article  Google Scholar 

  8. Kim BR, Lim JH, Lee SA, Kim JH, Koh SE, Lee IS, et al. The relation between postvoid residual and occurrence of urinary tract infection after stroke in rehabilitation unit. Ann Rehabil Med. 2012;36(2):248–53.

    Article  Google Scholar 

  9. Krebs J, Wöllner J, Pannek J. Risk factors for symptomatic urinary tract infections in individuals with chronic neurogenic lower urinary tract dysfunction. Spinal Cord. 2016;54(9):682–6.

    Article  CAS  Google Scholar 

  10. Omar M, Abdul wahab-Ahmed A, Chaparala H, Monga M. Does stone removal help patients with recurrent urinary tract infections? J Urol. 2015;194(4):997–1001.

    Article  Google Scholar 

  11. Castle AC, Park A, Mitchell AJ, et al. Neurogenic bladder: recurrent urinary tract infections—beyond antibiotics. Curr Bladder Dysfunct Rep. 2018;13:191.

    Article  Google Scholar 

  12. Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization. J Spinal Cord Med. 2009;32(5):568–73.

    Article  Google Scholar 

  13. Tuel SM, Meythaler JM, Cross LL, McLaughlin S. Cost-effective screening by nursing staff for urinary tract infection in the spinal cord injured patient. Am J Phys Med Rehabil. 1990;69(3):128–31.

    Article  CAS  Google Scholar 

  14. National Institute on Disability and Rehabilitation Research Statement. The prevention and management of urinary tract infections amongst people with spinal cord injuries. J Am Paraplegia Soc. 1992;15:194–204.

    Article  Google Scholar 

  15. Hoffman JM, Wadhwani R, Kelly E, Dixit B, Cardenas DD. Nitrite and leukocyte dipstick testing for urinary tract infection in individuals with spinal cord injury. J Spinal Cord Med. 2004;27(2):128–32.

    Article  Google Scholar 

  16. Frimodt-Møller N, Espersen F. Evaluation of calibrated 1 and 10 microl loops and dipslide as compared to pipettes for detection of low count bacteriuria in vitro. APMIS. 2000;108(78):525–30.

    Article  Google Scholar 

  17. Hess MJ, Zhan EH, Foo DK, Yalla SV. Bladder cancer in patients with spinal cord injury. J Spinal Cord Med. 2003;26(4):335–8.

    Article  Google Scholar 

  18. Soergel TM, Cain MP, Misseri R, Gardner TA, Koch MO, Rink RC. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172:1649–51.

    Article  Google Scholar 

  19. Everaert K, Lumen N, Kerckhaert W, Willaert P, van Driel M. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg. 2009;64(4):335–40.

    Article  CAS  Google Scholar 

  20. Pannek J, Pannek-Rademacher S, Cachin-Jus M. Organ-preserving treatment of an epididymal abscess in a patient with spinal cord injury. Spinal Cord. 2014;52(Suppl 1):S7–8.

    Article  Google Scholar 

  21. Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, et al. Summary of European Association of Urology (EAU) guidelines on neuro-urology. Eur Urol. 2016;69(2):324–33.

    Article  Google Scholar 

  22. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA. Guidelinefor preventionofcatheter-associatedurinarytractinfections. Infect Control Hosp Epidemiol. 2010;31(4):319–26. Retrieved from. https://doi.org/10.1086/651091.

    Article  PubMed  Google Scholar 

  23. Prieto JA, Murphy C, Moore KN, Fader MJ. Intermittent catheterisation for long-term bladder management (abridge Cochrane Review). Neurourol Urodyn. 2015;34(7):648–53.

    Article  Google Scholar 

  24. Cooper FP, Alexander CE, Sinha S, et al. Policies for replacing long-term indwelling urinary catheters in adults. Cochrane Database Syst Rev. 2016;(7):CD011115.

    Google Scholar 

  25. National Clinical Guideline Centre (NICE). Infection: prevention and control of healthcare-associated infections in primary and community care: partial update of NICE clinical guideline 2 (UK). 2012;10(139). https://www.ncbi.nlm.nih.gov/books/NBK115272/.

  26. Cicione A, Cantiello F, Ucciero G, Salonia A, Torella M, de Sio M, et al. Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: results from a multicentre survey. Can Urol Assoc J. 2014;8(9–10):E721–7. https://doi.org/10.5489/cuaj.1989.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625–63.

    Article  Google Scholar 

  28. Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA. 2014;311(8):844–54.

    Article  CAS  Google Scholar 

  29. Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, et al. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010;10:94.

    Article  Google Scholar 

  30. Hess MJ, Hess PE, Sullivan MR, et al. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord. 2008;46:622–6.

    Article  CAS  Google Scholar 

  31. Asma B, Vicky L, Stephanie D, Yves D, Amy H, Sylvie D. Standardised high dose versus low dose cranberry proanthocyanidin extracts for the prevention of recurrent urinary tract infection in healthy women [PACCANN]: a double blind randomised controlled trial protocol. BMC Urol. 2018;18(1):29.

    Article  Google Scholar 

  32. Toh S, Bonne Lee B, Ryan S, et al. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial. Spinal Cord. 2019;57:550–61. https://doi.org/10.1038/s41393-019-0251-y.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Castelló T, Girona L, Gómez MR, Mena Mur A, García L. The possible value of ascorbic acid as a prophylactic agent for urinary tract infection. Spinal Cord. 1996;34(10):592–3.

    Article  Google Scholar 

  34. Hetey SK, Kleinberg ML, Parker WD, Johnson EW. Effect of ascorbic acid on urine pH in patients with injured spinal cords. Am J Hosp Pharm. 1980;37(2):235–7.

    CAS  PubMed  Google Scholar 

  35. Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;(10):CD003265.

    Google Scholar 

  36. Altarac S, Papeš D. Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU Int. 2014;113(1):9–10.

    Article  Google Scholar 

  37. Phé V, Pakzad M, Haslam C, et al. Open label feasibility study evaluating d-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis. Neurourology and Urodynamics. 2017;36:1770–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Salisbury District Hospital, Wiltshire, UK

    Mostafa Ragab & Melissa Davies

  2. Royal Berkshire Hospital, Reading, GB, UK

    Bob Yang

Authors
  1. Mostafa Ragab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bob Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Melissa Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mostafa Ragab .

Editor information

Editors and Affiliations

  1. Royal Berkshire Hospital, Reading, UK

    Bob Yang

  2. Royal Berkshire Hospital, Reading, UK

    Steve Foley

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ragab, M., Yang, B., Davies, M. (2020). Urinary Tract Infections of the Neurogenic Bladder. In: Yang, B., Foley, S. (eds) Female Urinary Tract Infections in Clinical Practice. In Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-27909-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27909-7_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27908-0

  • Online ISBN: 978-3-030-27909-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation